MGMT methylation status as a prognostic factor in anaplastic astrocytomas

被引：0
|
作者：
Tosoni, A. [1 ,2 ,3 ,4 ,5 ]
Franceschi, E. [1 ,2 ,3 ,4 ,5 ]
Ermani, M. [1 ,2 ,3 ,4 ,5 ]
Bacci, A. [1 ,2 ,3 ,4 ,5 ]
Volpin, L. [1 ,2 ,3 ,4 ,5 ]
Lombardo, L. [1 ,2 ,3 ,4 ,5 ]
Ravenna, G. [1 ,2 ,3 ,4 ,5 ]
Pinna, G. [1 ,2 ,3 ,4 ,5 ]
Poggi, R. [1 ,2 ,3 ,4 ,5 ]
Brandes, A. A. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Bellaria Maggiore Hosp, Bologna, Italy
[2] Azienda Hosp Univ, Padua, Italy
[3] Hosp Civile, Vicenza, Italy
[4] Azienda Hosp, Verona, Italy
[5] Policlin Modena, Modena, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2052
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Methylation status of MGMT gene promoter in meningiomas
    de Robles, Paula
    McIntyre, John
    Kalra, Sanjog
    Roldan, Gloria
    Cairncross, Gregory
    Forsyth, Peter
    Magliocco, Tony
    Hamilton, Mark
    Easaw, Jacob
    CANCER GENETICS AND CYTOGENETICS, 2008, 187 (01) : 25 - 27
  • [42] Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma
    Haque, Waqar
    Teh, Caitlyn
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (01) : 137 - 146
  • [43] Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma
    Waqar Haque
    Caitlyn Teh
    E. Brian Butler
    Bin S. Teh
    Journal of Neuro-Oncology, 2022, 157 : 137 - 146
  • [44] Improved prognostic accuracy of alternative MGMT methylation status cutpoint: A single institution experience.
    Easaw, Jacob
    Gloria, Roldan
    Batuyong, Eugene
    Kornaga, Elizabeth
    Almuqate, Abdullah
    Sayeed, Wajid
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] MGMT promoter methylation status in clival chordoma
    Gianluca Marucci
    Luca Morandi
    Diego Mazzatenta
    Giorgio Frank
    Ernesto Pasquini
    Maria Pia Foschini
    Journal of Neuro-Oncology, 2014, 118 : 271 - 276
  • [46] Gemistocytes in astrocytomas:: Are they a significant prognostic factor?
    Martins, Dely C.
    Malheiros, Suzana M.
    Santiago, Lucila H.
    Stavale, Joao N.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 80 (01) : 49 - 55
  • [47] Gemistocytes in astrocytomas: Are they a significant prognostic factor?
    Dely C. Martins
    Suzana M. Malheiros
    Lucila H. Santiago
    João N. Stávale
    Journal of Neuro-Oncology, 2006, 80 : 49 - 55
  • [48] PROGNOSTIC VALUE OF MGMT METHYLATION IN IDH MUTANT GLIOMAS
    Lam, Keng
    Eldred, Blaine
    Kevan, Bryan
    Ji, Matthew
    Lou, Jerry
    Pianka, Sean
    Yong, William
    Liau, Linda
    Nghiemphu, Phioanh
    Cloughesy, Timothy
    Green, Richard
    Lai, Albert
    NEURO-ONCOLOGY, 2020, 22 : 8 - 8
  • [49] MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
    Szylberg, Mateusz
    Sokal, Pawel
    Sledzinska, Paulina
    Bebyn, Marek
    Krajewski, Stanislaw
    Szylberg, Lukasz
    Szylberg, Aneta
    Szylberg, Tadeusz
    Krystkiewicz, Kamil
    Birski, Marcin
    Harat, Marek
    Wlodarski, Robert
    Furtak, Jacek
    BIOMEDICINES, 2022, 10 (08)
  • [50] IMPLICATIONS OF MGMT METHYLATION STATUS IN PITUITARY ADENOMA AND CORRELATION WITH MGMT PROTEIN EXPRESSION
    Arimappamagan, Arivazhagan
    Arya, Sneha
    Majaid, M. A.
    Somanna, Sampath
    Santosh, Vani
    NEURO-ONCOLOGY, 2013, 15 : 99 - 99
12345